STING1 and breast carcinoma: Further evidence found that the cGAS-STING pathway induces inflammatory response through IL-6, IL-6R and STAT3 (Hong et al., 2022), and induces CD8+T cell infiltration to enhance anti-tumor immune responses in breast cancer (Pantelidou et al., 2022).